| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.077 | 0.07 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.09 | 0.08 |